Insights
Insights From Our Experts
Articles
What You Need to Know as the European Union Embarks on Joint Health Technology Assessment (HTA)
Facing the “Fourth Hurdle” Member states of the European Union benefit from a centralised marketing authorisation process for medicinal products. Also, since its implementation in 1993, the European Medicines Agency (EMA) has assured pharmaceutical companies the…
New Legislation Supports Payment for Digital Therapeutics
Earlier this month, the Access to Digital Prescription Therapeutics Act of 2022 was introduced by Rep. Mike Thompson (D-CA) to the U.S. House of Representatives as H.R. 7051 and by Sen. Shelley Moore Capito (R-WV) to…
How Do We Pay for a Cure? How to Put a Price on Life-changing Treatments
The global cell and gene therapy market is expected to reach $13.8 billion by 2026, expanding at a compound annual growth rate of 12.4%. — Global Cell & Gene Therapy Manufacturing Services Market by Type –…
Is Your Salesforce Keeping Up With Rapidly Evolving HCP Preferences?
Krista Pinto, President, Deployment Solutions, participated in a panel alongside industry leaders at Reuters Events: Pharma USA 2022. The discussion analyzed how pharmaceutical salesforces must progress in tandem with rapidly evolving healthcare providers (HCPs) and illustrated…
Podcast: Achieving Cell and Gene Therapy Commercial Excellence
There is no question about the incredible clinical impact cell and gene therapies (CGTs) can have on the lives of patients. However, this impact is the result of innovation that does not equate to a simple,…
Gene Therapy in Today’s Digital World
Rare diseases are an emerging global public health priority, with a staggering impact on the more than 300 million people worldwide who are living with them. There are more than 6,000 rare diseases, 72% of which…
How Can Utilizing Digital Therapeutics Provide Better Care to the Veteran Population?
EVERSANA’s Joe Perekupka, Chief Commercial Officer, participated in a keynote panel discussion at the recent DTx West Summit: “How Can Utilizing Digital Therapeutics Provide Better Care to the Veteran Population?” Joe was joined by moderator Debra…
Prescription Digital Therapeutics Coding: A Good First Step by CMS
The Centers for Medicare and Medicaid Services (CMS) recently issued a new code under the Healthcare Common Procedural Coding System (HCPCS) regarding prescription digital therapeutics (PDTs). These types of therapies are generally app- or device-based and…
Understanding Current Trends and Needs: Medical Information Contact Center Services
“Understanding Current Trends and Needs: Medical Information Contact Center Services,” a poster by EVERSANA’s Michael DeLuca, Senior Vice President, Medical Affairs, and Keyur Brahmbhatt, Director, Medical Affairs, along with Evelyn Hermes-DeSantis, Director, Research and Publications, phactMI,…
Succeed When Others Fail: Avoiding 20% in Investment Waste During Launch
It’s a long-standing perception that pharma overspends during launch, but we did not have the data or methodology to understand or validate this notion. Until now. New Research by the Numbers 10: Recent analysis across 10…